According to Health Care Risk Management standards supported by ASHRM and patient safety principles endorsed by The Joint Commission, the most likely root cause of medication errors is system or process failure. Modern patient safety frameworks emphasize that errors rarely result from isolated individual mistakes. Instead, they typically arise from weaknesses in processes, workflow design, communication systems, technology integration, or inadequate safeguards.

Illegible handwriting, manual systems, and look-alike or sound-alike drugs are recognized contributing factors. However, these elements represent components within a broader system. For example, illegible handwriting becomes problematic when standardized order entry systems are lacking. Look-alike medications pose risks when storage, labeling, or verification processes are insufficient. Manual medication delivery systems increase risk when redundancy and double-check mechanisms are absent.

Root cause analysis methodologies consistently demonstrate that unsafe system design, poor communication processes, lack of standardized procedures, and inadequate training contribute to medication errors. A systems-based approach aligns with just culture principles and focuses on improving processes rather than assigning individual blame.

Clinical and patient safety objectives emphasize system redesign, standardization, and continuous quality improvement. Therefore, system or process failure is the most likely root cause of medication errors.

According to Health Care Risk Management standards endorsed by ASHRM and the American Hospital Association Certification Center, system-level issues in the informed consent process should first be addressed through quality improvement and educational interventions rather than immediate punitive action.

Conducting a medical record audit is an appropriate first step to identify patterns of incomplete documentation and determine whether the problem is isolated or systemic. Reviewing and revising policies and procedures ensures alignment with current legal standards and clarifies responsibilities for obtaining and documenting consent. Providing targeted education to physicians, nurses, and office staff reinforces understanding of required elements, including discussion of risks, benefits, alternatives, and patient questions.

Reporting physicians with incomplete consent forms directly to peer review may be appropriate in cases of persistent noncompliance or willful disregard of standards. However, when a systemic process problem is identified, immediate referral to peer review is not the appropriate primary intervention and may undermine a just culture approach.

Clinical and patient safety objectives emphasize root cause identification, education, and process improvement before disciplinary escalation. Therefore, reporting physicians to peer review in this context represents the inappropriate intervention.

According to Health Care Risk Management standards supported by ASHRM and accreditation guidance from The Joint Commission, patient-owned electrical devices brought into healthcare facilities must be evaluated to ensure they do not pose safety risks. The Joint Commission’s Environment of Care standards emphasize electrical safety, fire prevention, and reduction of hazards within patient care areas.

Before a patient-owned electrical device is used within the facility, an electrical safety inspection should be conducted to assess the integrity of cords, plugs, grounding, and overall condition. The purpose is to identify potential risks such as frayed wiring, overheating hazards, or improper voltage compatibility that could endanger patients, staff, or equipment.

Simply inventorying the device with personal belongings does not address safety concerns. Sequestering the device may be appropriate if it fails inspection, but routine confiscation is not required. While biomedical engineering departments often assist with inspections, tagging by biomedical engineering is not itself the required action; the essential requirement is that a safety inspection be performed.

Clinical and patient safety objectives emphasize proactive hazard identification and compliance with accreditation standards. Therefore, conducting an electrical safety inspection is the appropriate action for patient-owned electrical devices entering the facility.

Discoverability of incident reports varies substantially by jurisdiction and depends on how state and federal laws define peer review privilege, quality improvement protections, and confidentiality—plus how courts interpret those protections. Risk management objectives include structuring reporting and investigation workflows to maximize protected quality review where legally available: routing analyses through designated committees, labeling and handling documents per policy, limiting distribution, and avoiding mixing risk/peer review materials with ordinary business records. However, privilege is not automatic; mishandling (broad email distribution, using reports for disciplinary actions outside protected structures, inconsistent committee practices) can weaken protections. A defensible program uses legal counsel guidance, staff training, and clear documentation rules so the organization learns from events while reducing unnecessary legal exposure.

EMTALA creates federal obligations for emergency screening and stabilization/appropriate transfer when an individual presents for emergency care. CMS interpretive guidance states a hospital’s EMTALA obligation ends when the individual is admitted in good faith for inpatient services (even if not stabilized), shifting responsibility to inpatient Conditions of Participation and standard malpractice frameworks. EMTALA obligations also end following stabilization or an appropriate transfer (with required documentation/acceptance). Risk management objectives include tight ED documentation, clear decision points (screening complete, EMC identified, stabilization initiated, transfer accepted), and policy training to prevent EMTALA violations (which can carry major regulatory and financial consequences). The incorrect notion that EMTALA ends when contact information is provided is not supported; discharge planning is important, but it does not terminate EMTALA duties.